A Phase II Study of Concurrent Nab-Paclitaxel, Carboplatin and Thoracic Radiotherapy in Local Advanced Squamous Cell Lung Cancer
Phase of Trial: Phase II
Latest Information Update: 04 Dec 2017
At a glance
- Drugs Paclitaxel (Primary) ; Carboplatin
- Indications Non-small cell lung cancer; Squamous cell cancer
- Focus Therapeutic Use
- 13 Dec 2015 Planned End Date changed from 1 Jun 2016 to 1 Jun 2017, according to ClinicalTrials.gov record.
- 13 Dec 2015 Planned primary completion date changed from 1 Jul 2015 to 1 Jul 2016, according to ClinicalTrials.gov record.
- 21 Dec 2011 New trial record